Status:
RECRUITING
AI-Powered ECG Detecting Culprit Vessel Blood Flow Abnormality in ACS
Lead Sponsor:
Powerful Medical
Conditions:
Acute Coronary Syndrome
STEMI
Eligibility:
All Genders
18-85 years
Brief Summary
AI ECG TIMI is an investigator-initiated, international, and multicenter registry of acute coronary syndrome patients aimed to identify electrocardiographic findings detected by an AI model predicting...
Eligibility Criteria
Inclusion
- Patients with acute coronary syndromes undergoing invasive coronary angiography as clinically indicated.
- Availability of a standard 12-lead ECG performed at invasive coronary angiogram before percutaneous coronary intervention (maximum within 15 min before vascular access).
- Age ≥18 years.
Exclusion
- Individuals presenting for a non-emergent (elective) cardiac catheterization.
- Individuals presenting with chronic coronary syndrome (CCS) or stable angina symptoms.
- Individuals without symptoms suspicious for acute coronary syndromes.
- Individuals with contraindications for cardiac catheterization.
Key Trial Info
Start Date :
December 10 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT06528821
Start Date
December 10 2024
End Date
October 1 2025
Last Update
April 29 2025
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
LKH Hochsteiermark, Standort Bruck
Bruck an der Mur, Austria
2
LKH II Standort West
Graz, Austria, 8020
3
Medical University of Graz
Graz, Austria
4
OLV Aalst
Aalst, Belgium